Skip to content
Search

Latest Stories

Scottish community pharmacies global sum remuneration increased by 6 per cent to £220 million for 2023-24

Following discussions with Community Pharmacy Scotland, the Scottish government has agreed to a six per cent rise in the global fund allocation for community pharmacies in 2023-24, bringing the total remuneration to approximately £219.5 million.

A finalised agreement has been reached with Community Pharmacy Scotland for a one-year funding package for the financial year 2023-24, as stated in a Scottish government circular distributed to community pharmacy contractors and NHS Boards on August 4.


The circular said this settlement will lead to the most substantial increment ever approved for the community pharmacy network.

“The global sum remuneration will be £219.533 million, signifying a 6 per cent increase from the previous year and setting the groundwork for 2024/25," stated Professor Alison Strath, Chief Pharmaceutical Officer for Scotland, in the document. "The guaranteed income from the drug tariff will remain at £80 million for the financial year, without yearly changes."

However, the current level of guaranteed minimum income has increased by £15.95 million (19 per cent) to £100 million. “The delivery of the guaranteed minimum income will be closely monitored monthly throughout the year and further action to support contractor cashflow will be considered if appropriate,” Strath added.

As per the circular, details about margin sharing arrangements will be furnished in the upcoming weeks, guided by findings from the Scottish Government's community pharmacy regular pricing inquiry report.

According to the document, community pharmacy contractors will receive a one-off payment from an agreed fund of £1.66 million. "Payment will be calculated based on the activity in the April dispensing pool. This payment will adhere to a schedule where it's processed in June but will be distributed or paid out in August. This acknowledges the absence of a drug tariff adjustment for April 2023."

Community Pharmacy Scotland described the agreement as mutually beneficial, offering a more stable financial perspective for pharmacies following a demanding 2022-23 characterised by financial, workforce, and workload pressures. "This guaranteed minimum income comes from the reimbursement aspect of our financial structure. It represents the lowest amount we consider acceptable this year from the Tariff, designed to aid the expenses of service provision throughout our financial framework,” said CPS.

"We are currently working with Scottish government to fine-tune the details of how we would handle underperformance, aiming for this to be a responsive measure to protect our cashflow,” CPS added.

The new funding agreement for 2023-24, involving over 1,200 community pharmacies, was initially announced on July 21. However, specific details weren't made public until two weeks later.

During his UCL School of Pharmacy Lecture in June, CPS CEO Professor Harry McQuillan urged UK pharmacists to prioritise 'safety of supply' over 'accuracy of supply' for patients. He emphasised investing in teams, technology, and embracing a more clinical future to ensure maximum benefits from prescribed medicines.

More For You

Lack of funding deters NI pharmacy contractors from expanding portfolio

W G Hamilton Pharmacy is the third pharmacy in Northern Ireland to be recently sold to first-time buyers.

Pharmacy ownership trends shift in Northern Ireland due to funding gap

An increasing number of pharmacies in Northern Ireland are being acquired by first-time buyers, as existing contractors and groups pull back from expanding their portfolios amid ongoing funding pressures, according to specialist business property adviser Christie & Co.

Among the most recent sales is W G Hamilton Pharmacy, a busy community pharmacy in Ballysillan, North Belfast.

Keep ReadingShow less
RPS backs Pharmacist Support "Gift in Wills" initiative

The ‘Gift in Wills’ initiative is delivered in partnership with Bequeathed.

Photo credit: gettyimages

Leave a legacy: RPS partners with Pharmacist Support to promote ‘Gift in Wills’

The Royal Pharmaceutical Society (RPS) has announced its support for the ‘Gift in Wills’ initiative run by Pharmacist Support, coinciding with the charity’s birthday celebrations today (Tuesday 15 April).

This collaboration allows RPS members to create a free will while also helping to safeguard the future of vital support services for the pharmacy profession.

Keep ReadingShow less
Pharmacist Support calls for birthday donations to meet rising demand for mental health services

More and more pharmacy professionals are reaching out for help, said Danielle Hunt.

Pharmacist Support's birthday appeal: Donate to address growing mental health demand

Pharmacist Support – the independent charity dedicated to the pharmacy profession – is celebrating 184 years of service with the launch of a special birthday donations appeal.

On 15 April, the charity is urging individuals and organisations across the sector to support its campaign to raise vital funds to meet the increasing demand for its mental health and wellbeing services.

Keep ReadingShow less
Prostate cancer: At-home saliva test could save NHS £500 million annually

PRS saliva test can identify prostate cancer that was missed by an MRI scan

Photo credit: gettyimages

Prostate cancer: Spit test better than blood test in spotting men at highest risk

A simple at-home spit test could help detect prostate cancer earlier, saving the NHS around £500 million a year, according to new research published in the New England Journal of Medicine.

Funded by the National Institute for Health and Care Research (NIHR), the study found that the DNA-based saliva test was more accurate than the current prostate-specific antigen (PSA) blood test in identifying men at risk of developing prostate cancer.

Keep ReadingShow less
RPS launches innovative new learning resources for members

With RPS Learn, pharmacists can develop a new skill or improve their understanding of practice or a clinical topic.

Gettyimages

RPS launches new learning resources to boost career development for members

The Royal Pharmaceutical Society (RPS) has launched a new online learning platform designed to support the practice, development and career advancement of its members.

The new platform, called RPS Learn, offers a diverse range of bite-size learning content, available on-demand, catering to all levels — from introductory to advanced and specialist —combining new content with RPS's renowned expertise in education and training to achieve excellence for learners.

Keep ReadingShow less